Home › Idiopathic Pulmonary Fibrosis › Oregon
Idiopathic Pulmonary Fibrosis clinical trials in Oregon
3 studies for Idiopathic Pulmonary Fibrosis are looking for participants at sites in Oregon.
An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)
- Summit Health, Bend
- The Oregon Clinic Pulmonary East, Portland
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT06951217Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)
- Bend Memorial Hospital, Bend
RecruitingPhase 2
Ages 40 and older · All sexes · Updated Sep 2, 2026 · NCT05571059Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
- Oregon Clinic, Portland
RecruitingObservational study
Ages 21 and older · All sexes · Updated Aug 12, 2026 · NCT01915511From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.